Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지
DOI QR코드

DOI QR Code

Efficacy of botulinum toxin in the management of temporomandibular myofascial pain and sleep bruxism

  • Hosgor, Hatice (Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Kocaeli University) ;
  • Altindis, Sezen (Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Kocaeli University)
  • Received : 2020.03.03
  • Accepted : 2020.05.19
  • Published : 2020.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study sought to evaluate the efficacy of injecting botulinum toxin into the masseter and temporal muscles in patients with temporomandibular myofascial pain and sleep bruxism. Materials and Methods: The study was conducted based on a clinical record review of 44 patients (36 females and eight males; mean age, 35.70±12.66 years). Patients who underwent the injection of botulinum toxin into the masseter and temporal muscles for the management of temporomandibular myofascial pain and sleep bruxism were included in the study. Patients were diagnosed based on the Diagnostic Criteria for Temporomandibular Disorders. Sleep bruxism was diagnosed according to the criteria defined by the American Academy of Sleep Medicine. The values of the visual analogue scale (VAS) and range of jaw motion, including unassisted maximum mouth opening (MMO), protrusion, and right and left laterotrusion, were observed preoperatively and postoperatively at one-, three-, and six-month follow-up visits. Results: MMO, movements of the right and the left laterotrusion, and protrusion increased significantly (P<0.05), while VAS ratings decreased significantly at the three follow-up points relative to baseline values (P<0.05). Conclusion: Botulinum toxin is an effective treatment for patients with temporomandibular myofascial pain and sleep bruxism.

Keywords

References

  1. Lora VR, Canales Gde L, Goncalves LM, Meloto CB, Barbosa CM. Prevalence of temporomandibular disorders in postmenopausal women and relationship with pain and HRT. Braz Oral Res 2016;30:e100. https://doi.org/10.1590/1807-3107BOR-2016.vol30.0100
  2. Nayyar P, Kumar P, Nayyar PV, Singh A. Botox: broadening the horizon of dentistry. J Clin Diagn Res 2014;8:ZE25-9. https://doi.org/10.7860/JCDR/2014/11624.5341
  3. Miloro M, Ghali GE, Larsen P, Waite P. Peterson's principles of oral and maxillofacial surgery. 3rd ed. Shelton: People's Medical Publishing House; 2012.
  4. Maini K, Dua A. Temporomandibular joint syndrome [Internet]. Treasure Island (FL): StatPearls Publishing [cited 2020 May 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551612/.
  5. Koyano K, Tsukiyama Y, Ichiki R, Kuwata T. Assessment of bruxism in the clinic. J Oral Rehabil 2008;35:495-508. https://doi.org/10.1111/j.1365-2842.2008.01880.x
  6. Jimenez-Silva A, Pena-Duran C, Tobar-Reyes J, Frugone-Zambra R. Sleep and awake bruxism in adults and its relationship with temporomandibular disorders: a systematic review from 2003 to 2014. Acta Odontol Scand 2017;75:36-58. https://doi.org/10.1080/00016357.2016.1247465
  7. Macfarlane TV, Gray RJM, Kincey J, Worthington HV. Factors associated with the temporomandibular disorder, pain dysfunction syndrome (PDS): Manchester case-control study. Oral Dis 2001;7:321-30. https://doi.org/10.1034/j.1601-0825.2001.00758.x
  8. Glaros AG, Burton E. Parafunctional clenching, pain, and effort in temporomandibular disorders. J Behav Med 2004;27:91-100. https://doi.org/10.1023/b:jobm.0000013646.04624.8f
  9. van der Meulen MJ, Lobbezoo F, Aartman IH, Naeije M. Self-reported oral parafunctions and pain intensity in temporomandibular disorder patients. J Orofac Pain 2006;20:31-5.
  10. Magnusson T, Egermarki I, Carlsson GE. A prospective investigation over two decades on signs and symptoms of temporomandibular disorders and associated variables. A final summary. Acta Odontol Scand 2005;63:99-109. https://doi.org/10.1080/00016350510019739
  11. Ciancaglini R, Gherlone EF, Radaelli G. The relationship of bruxism with craniofacial pain and symptoms from the masticatory system in the adult population. J Oral Rehabil 2001;28:842-8. https://doi.org/10.1046/j.1365-2842.2001.00753.x
  12. Uchida M, Yatani H, Ishigaki S, Toda M, Morimoto K. Relations among TMD, bruxism, lifestyle, and psychological stress. Prosthodont Res Pract 2008;7:171-3. https://doi.org/10.2186/prp.7.171
  13. Lobbezoo F, Ahlberg J, Raphael KG, Wetselaar P, Glaros AG, Kato T, et al. International consensus on the assessment of bruxism: report of a work in progress. J Oral Rehabil 2018;45:837-44. https://doi.org/10.1111/joor.12663
  14. Manfredini D, Winocur E, Guarda-Nardini L, Paesani D, Lobbezoo F. Epidemiology of bruxism in adults: a systematic review of the literature. J Orofac Pain 2013;27:99-110. https://doi.org/10.11607/jop.921
  15. Maluly M, Andersen ML, Dal-Fabbro C, Garbuio S, Bittencourt L, de Siqueira JT, et al. Polysomnographic study of the prevalence of sleep bruxism in a population sample. J Dent Res 2013;92(7 Suppl):97S-103S. https://doi.org/10.1177/0022034513484328
  16. Ohayon MM, Li KK, Guilleminault C. Risk factors for sleep bruxism in the general population. Chest 2001;119:53-61. https://doi.org/10.1378/chest.119.1.53
  17. American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien (IL): American Academy of Sleep Medicine; 2014:303-11.
  18. Suvinen TI, Reade PC, Hanes KR, Kononen M, Kemppainen P. Temporomandibular disorder subtypes according to self-reported physical and psychosocial variables in female patients: a reevaluation. J Oral Rehabil 2005;32:166-73. https://doi.org/10.1111/j.1365-2842.2004.01432.x
  19. List T, Axelsson S. Management of TMD: evidence from systematic reviews and meta-analyses. J Oral Rehabil 2010;37:430-51. https://doi.org/10.1111/j.1365-2842.2010.02089.x
  20. Freund B, Schwartz M, Symington JM. The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. J Oral Maxillofac Surg 1999;57:916-20; discussion 920-1. https://doi.org/10.1016/s0278-2391(99)90007-1
  21. Lee KM, Chow J, Hui E, Li W. Botulinum toxin type A injection for the management of myofascial temporomandibular pain disorder. Asian J Oral Maxillofac Surg 2005;17:100-3. https://doi.org/10.1016/S0915-6992(05)80032-9
  22. De la Torre Canales G, Camara-Souza MB, do Amaral CF, Garcia RC, Manfredini D. Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature review. Clin Oral Investig 2017;21:727-34. https://doi.org/10.1007/s00784-017-2092-4
  23. Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, et al.; International RDC/TMD Consortium Network, International association for Dental Research; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache 2014;28:6-27. https://doi.org/10.11607/jop.1151
  24. Nitzan DW. Intraarticular pressure in the functioning human temporomandibular joint and its alteration by uniform elevation of the occlusal plane. J Oral Maxillofac Surg 1994;52:671-9; discussion 679-80. https://doi.org/10.1016/0278-2391(94)90476-6
  25. Sharav Y, Benoliel R. Orofacial pain & headache. Edinburgh: Mosby; 2008:161.
  26. Gulec M, Tassoker M, Ozcan S. [Bruksizmin tani ve tedavisinde guncel yaklasimlar]. Selcuk Dent J 2019;6:221-8. Turkish.
  27. Tinastepe N, Kucuk BB, Oral K. Botulinum toxin for the treatment of bruxism. Cranio 2015;33:291-8. https://doi.org/10.1080/08869634.2015.1097296
  28. Manfredini D, Lobbezoo F. Relationship between bruxism and temporomandibular disorders: a systematic review of literature from 1998 to 2008. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109:e26-50. https://doi.org/10.1016/j.tripleo.2010.02.013
  29. Ariji Y, Sakuma S, Izumi M, Sasaki J, Kurita K, Ogi N, et al. Ultrasonographic features of the masseter muscle in female patients with temporomandibular disorder associated with myofascial pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:337-41. https://doi.org/10.1016/j.tripleo.2004.06.068
  30. Abouelhuda AM, Khalifa AK, Kim YK, Hegazy SA. Non-invasive different modalities of treatment for temporomandibular disorders: review of literature. J Korean Assoc Oral Maxillofac Surg 2018;44:43-51. https://doi.org/10.5125/jkaoms.2018.44.2.43
  31. Fernandez-Nunez T, Amghar-Maach S, Gay-Escoda C. Efficacy of botulinum toxin in the treatment of bruxism: systematic review. Med Oral Patol Oral Cir Bucal 2019;24:e416-24. https://doi.org/10.4317/medoral.22923
  32. Al-Wayli H. Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study. J Clin Exp Dent 2017;9:e112-7. https://doi.org/10.4317/jced.53084
  33. Sidebottom AJ, Patel AA, Amin J. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study. Br J Oral Maxillofac Surg 2013;51:199-205. https://doi.org/10.1016/j.bjoms.2012.07.002
  34. Ahn J, Horn C, Blitzer A. Botulinum toxin for masseter reduction in Asian patients. Arch Facial Plast Surg 2004;6:188-91. https://doi.org/10.1001/archfaci.6.3.188
  35. Majid OW. Clinical use of botulinum toxins in oral and maxillofacial surgery. Int J Oral Maxillofac Surg 2010;39:197-207. https://doi.org/10.1016/j.ijom.2009.10.022
  36. Dressler D, Saberi FA, Barbosa ER. Botulinum toxin: mechanisms of action. Arq Neuropsiquiatr 2005;63:180-5. https://doi.org/10.1590/s0004-282x2005000100035
  37. Lee SJ, McCall WD Jr, Kim YK, Chung SC, Chung JW. Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial. Am J Phys Med Rehabil 2010;89:16-23. https://doi.org/10.1097/PHM.0b013e3181bc0c78
  38. Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio 2008;26:126-35. https://doi.org/10.1179/crn.2008.017
  39. Guarda-Nardini L, Stecco A, Stecco C, Masiero S, Manfredini D. Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique. Cranio 2012;30:95-102. https://doi.org/10.1179/crn.2012.014
  40. Ernberg M, Hedenberg-Magnusson B, List T, Svensson P. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. Pain 2011;152:1988-96. https://doi.org/10.1016/j.pain.2011.03.036
  41. Kim HS, Yun PY, Kim YK. A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment. Maxillofac Plast Reconstr Surg 2016;38:5. https://doi.org/10.1186/s40902-016-0051-7
  42. Kurtoglu C, Gur OH, Kurkcu M, Sertdemir Y, Guler-Uysal F, Uysal H. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. J Oral Maxillofac Surg 2008;66:1644-51. https://doi.org/10.1016/j.joms.2008.03.008
  43. Klein FH, Brenner FM, Sato MS, Robert FM, Helmer KA. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy. An Bras Dermatol 2014;89:878-84. https://doi.org/10.1590/abd1806-4841.20143200
  44. Borodic G. Botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications. Facial Plast Surg Clin North Am 2007;15:11-6, v. https://doi.org/10.1016/j.fsc.2006.10.001
  45. Chen YW, Chiu YW, Chen CY, Chuang SK. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials. Int J Oral Maxillofac Surg 2015;44:1018-26. https://doi.org/10.1016/j.ijom.2015.04.003

Cited by

  1. Intramuscular Injections and Dry Needling within Masticatory Muscles in Management of Myofascial Pain. Systematic Review of Clinical Trials vol.18, pp.18, 2020, https://doi.org/10.3390/ijerph18189552